Characterization of meningiomas with synthetic imaging

Brain Behav. 2022 Nov;12(11):e2769. doi: 10.1002/brb3.2769. Epub 2022 Oct 12.

Abstract

Introduction: Synthetic magnetic resonance imaging (SyMRI) is a novel quantitative and qualitative technique that permits the reconstruction of multiple image contrasts and quantitative maps from a single scan, thereby providing quantitative information and reducing scan times. The purpose of this study is to characterize intracranial meningiomas using SyMRI.

Methods: The study included 35 patients with meningiomas (6 males, 29 females; mean age 61 ± 17 years; range 21-90 years). Using 3T MR scanners, SyMRI was performed in addition to conventional FSET2, FLAIR, DWI, T1, and T1 with gadolinium. SyMRI software was used to generate T1, T2, and PD quantitative maps. Osirix MD was used to measure quantitative values of T1, T2, and PD using a ROI.

Results: We analyzed 42 meningiomas, 8 of which were associated with edema, and 5 contained calcifications. Mean relaxivity values of meningiomas on synthetic T1, T2, and PD maps at 3T MRI were 1382.6 ± 391.7 ms, 95.6 ± 36.5 ms, and 89.1 ± 9.7 pu, respectively. Signal intensities in terms of T1, T2, and PD did not differ significantly between meningiomas with and without edema (p = .994, p = .356, and p = .221, respectively), nor between meningiomas containing and not containing calcifications (p = .840, p = .710, and p = .455, respectively). Values of T1 and T2 measured in meningiomas and the normal-appearing white matter approximated reference values found in the literature with other quantitative methods.

Conclusion: The presented method offers a novel approach to characterize meningiomas through their relaxation parameters measured with a SyMRI sequence.

Keywords: MRI; biomarkers; meningiomas; relaxivity values; synthetic imaging.

MeSH terms

  • Adult
  • Aged
  • Brain / pathology
  • Contrast Media
  • Female
  • Humans
  • Magnetic Resonance Imaging / methods
  • Male
  • Meningeal Neoplasms* / diagnostic imaging
  • Meningeal Neoplasms* / pathology
  • Meningioma* / diagnostic imaging
  • Meningioma* / pathology
  • Middle Aged

Substances

  • Contrast Media